...The double-blind, international Phase IIb MAyflOwer RoAD trial in about 544 patients with moderate severity AD...

...primary endpoint in a Phase IIb trial to treat moderately severe Alzheimer's disease. In the MAyflOwer...

...disclosed in its 1Q14 earnings that Roche completed enrollment of the placebo-controlled, international Phase IIb MAyflOwer...

...Nexus Medical Partners; and Pound Capital joined existing investors Apax Partners; Merlin Biosciences; Atlas Venture; Mayflower...

...Pharmaceuticals Co. (PPCO), Danbury, Conn. Business: Drug delivery Appointed: Peter Drake, managing general partner of Mayflower...

...Cortex Pharmaceuticals Inc. (COR), Irvine, Calif. Business: Neurology Appointed: Peter Drake, managing general partner of Mayflower...